AXA customers who suffer from Immune Mediated Inflammatory Disease such as Rheumatoid Arthritis to be provided comprehensive support including free consultation, education and home delivery of medicines.

In a yet another industry first towards providing innovative healthcare services, AXA Gulf has launched a unique ‘Patient Support Program’ in the UAE that is focused on providing comprehensive support to patients suffering from IMID. The new program has been introduced in collaboration with AbbVie, a research-based biopharmaceutical company, where the deal was signed with AbbVie South Gulf represented by Sami Abi Nakhoul the General Manager, and Bayti Home Healthcare, a company dedicated to provide patients with the medication they require at home. The program was unveiled recently at an event that was attended by executives from Dubai Healthcare Authority and leading doctors from the UAE.